Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot...

|By:, SA News Editor

Affymetrix (AFFX -0.8%) says it's subsidiary, eBioscience, has sold its TrueBlot IP/Western blot product line to Rockland Immunochemicals, a biotechnology company focusing on antibodies and antibody based tools for R&D and preclinical studies. TrueBlot reagents are used in Western blotting, a technique used in both scientific research and medical diagnosis to determine expression and quantitate target proteins in biological samples.